Studies have demonstrated that several σ2R ligands kill tumor cells by apoptosis and by various signaling pathways that include the p53 apoptotic pathway, caspase-dependent apoptotic pathway, impaired cell cycle progression, mTOR pathway, and EGFR signaling pathway. This evidence concerns the gene TP53 and neoplasm.